Public Company News

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids

* Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo * Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in...

2025-05-07 20:00 2945

Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaud...

2025-05-07 20:00 5647

accesso® Acquires Technology of 1RISK

Leading Online Waiver and Risk Management Data Solutions to Be Offered Exclusively via Expanded  accesso  Ecosystem TWYFORD, England, May 7, 2025 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the premier technology solutions provider for attractions and venues worldwide, today announced...

2025-05-07 20:00 2829

Dow and Pan Era Group advance their strategic partnership to increase the supply of high-quality PCR resins in Southeast Asia

With this new agreement, Dow will acquire its flexible polyethylene post-consumer recycled (PCR) resins from Pan Era Group. JAKARTA, Indonesia, May 7, 2025 /PRNewswire/ -- Dow (NYSE: DOW), a global leader in materials science, signed a second memorandum of understanding (MOU) with PT Eterna Per...

2025-05-07 18:53 4844

Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025

SHANGHAI, May 7, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced that it will release its unaudited financial results for the first quarter e...

2025-05-07 18:00 4459

Kuaishou Technology to Report 2025 First Quarter Financial Results on May 27, 2025

HONG KONG, May 7, 2025 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that it will report its unaudited consolidated first quarterly results for the ...

2025-05-07 17:05 4871

Elavon and Jscrambler Partner to Strengthen PCI DSS Compliance for Merchants

More Than 400 Merchants Within the Network Gain Access to Jscrambler's Leading Client-Side Protection for Skimming Prevention and Compliance MINNEAPOLIS and PORTO, Portugal, May 7, 2025 /PRNewswire/ -- Elavon, a global leader in payment processing, andJscrambler, a pioneer in client-side protec...

2025-05-07 16:00 4322

The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

* The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was significantly greater than that in the placebo group, of which the difference was statistically si...

2025-05-07 14:19 4166

Forrester Unveils Top 10 Emerging Technologies For 2025; AI Innovation Shifts From Experimentation To Business Imperative

Agentic AI represents the next frontier in automation, enabling systems to make decisions independently and with intent SINGAPORE, May 7, 2025 /PRNewswire/ -- As generative AI evolves into agentic AI, automation becomes more sophisticated, and emerging technologies shift to large-scale deployme...

2025-05-07 12:30 3079

NetDragon Participates in Digital China Summit for the 8th Consecutive Year, Pioneering AI-Driven Innovation in Gaming and Education

HONG KONG, May 7, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 0777), a global leader in building internet communities, is pleased to announce its participation in the 8th Digital China Summit, recently held in Fuzhou, Fujian Provinc...

2025-05-07 10:58 5148

Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development

Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore ...

2025-05-07 10:12 3143

CreateAI Releases White Paper on how AI Transforms Animation Production

BEIJING, May 6, 2025 /PRNewswire/ -- CreateAI Holdings Inc. (OTCMKTS: TSPH) ("CreateAI" or the "Company"), a global artificial intelligence technology company, today announced the release of its "White Paper on the Application and Development of Multimodal Generative Technology in Animation Produ...

2025-05-07 10:00 4916

LONGi and ENGIE Forge Powerful Partnership to Drive Solar Innovation with Hi-MO 9 BC Technology

Global Collaboration Accelerates Utility-Scale Solar Adoption with Disruptive Back Contact Technology PARIS, May 7, 2025 /PRNewswire/ -- LONGi, a world leading solar technology company, has secured a significant agreement withENGIE , a renowned global energy group, to ...

2025-05-07 09:32 3710

PEC Ltd. US$160 million buyout and privatization by Liberty Energy Solutions Ltd

SINGAPORE, May 7, 2025 /PRNewswire/ -- PEC Ltd ("PEC", SGX: IX2) shareholders have approved a transaction valued at US$160 million for the 100% acquisition by Alliance Energy Services Pte Ltd ("Alliance") through a Scheme of Arrangement at Extraordinary General Meeting in Singapore.  Following sa...

2025-05-07 09:00 3886

New Akamai Study Reveals API Security Incidents Cost APAC Enterprises Over US$580,000 on Average in the Past Year

Internal disconnects, poor visibility, and misaligned priorities leave organizations vulnerable to costly API security incidents SINGAPORE, May 7, 2025 /PRNewswire/ -- Akamai Technologies (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers and protects business online, tod...

2025-05-07 09:00 2627

Lake Resources Announces Exploration of Strategic Alternatives

SYDNEY, May 7, 2025 /PRNewswire/ -- Lake Resources N.L. (ASX: LKE; OTC: LLKKF) ("Lake" or the "Company"), a responsible lithium developer, announced today that its Board of Directors will form a Special Committee composed of all members of the Board of Directors to evaluate a full range of strate...

2025-05-07 08:12 4756

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

SUZHOU, China, May 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bis...

2025-05-07 08:00 3624

Bispecific vs. Bispecific: Innovent Announces First Patient Dosed in the Phase 2 Clinical Study of Efdamrofusp Alfa (IBI302), a First-in-class Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Diabetic Macular Edema

SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2025-05-07 08:00 4533

Everest Medicines Announces NMPA Full Approval of NEFECON® for the Treatment of Primary Immunoglobulin A nephropathy (IgAN) in Adults at Risk of Disease Progression

SHANGHAI, May 7, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that the supplemental New Drug Applica...

2025-05-07 07:30 3210

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inMexico for the commercialization of clobetasol propionate ophthalmic...

2025-05-07 06:30 6101